<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2018-01-31" version="171">
<accession>O76082</accession>
<accession>A2Q0V1</accession>
<accession>B2R844</accession>
<accession>D3DQ87</accession>
<accession>Q6ZQZ8</accession>
<accession>Q96EH6</accession>
<name>S22A5_HUMAN</name>
<protein>
<recommendedName>
<fullName>Solute carrier family 22 member 5</fullName>
</recommendedName>
<alternativeName>
<fullName>High-affinity sodium-dependent carnitine cotransporter</fullName>
</alternativeName>
<alternativeName>
<fullName>Organic cation/carnitine transporter 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SLC22A5</name>
<name type="synonym">OCTN2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="246" first="589" last="595">
<title>cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.</title>
<authorList>
<person name="Wu X."/>
<person name="Prasad P.D."/>
<person name="Leibach F.H."/>
<person name="Ganapathy V."/>
</authorList>
<dbReference type="PubMed" id="9618255"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8669"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="20378" last="20382">
<title>Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.</title>
<authorList>
<person name="Tamai I."/>
<person name="Ohashi R."/>
<person name="Nezu J."/>
<person name="Yabuuchi H."/>
<person name="Oku A."/>
<person name="Shimane M."/>
<person name="Sai Y."/>
<person name="Tsuji A."/>
</authorList>
<dbReference type="PubMed" id="9685390"/>
<dbReference type="DOI" id="10.1074/jbc.273.32.20378"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Nat. Genet." volume="21" first="91" last="94">
<title>Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.</title>
<authorList>
<person name="Nezu J."/>
<person name="Tamai I."/>
<person name="Oku A."/>
<person name="Ohashi R."/>
<person name="Yabuuchi H."/>
<person name="Hashimoto N."/>
<person name="Nikaido H."/>
<person name="Sai Y."/>
<person name="Koizumi A."/>
<person name="Shoji Y."/>
<person name="Takada G."/>
<person name="Matsuishi T."/>
<person name="Yashino M."/>
<person name="Kato H."/>
<person name="Ohura T."/>
<person name="Tsujimoto G."/>
<person name="Hayakawa J."/>
<person name="Shimane M."/>
<person name="Tsuji A."/>
</authorList>
<dbReference type="PubMed" id="9916797"/>
<dbReference type="DOI" id="10.1038/5030"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1773" first="1000" last="1006">
<title>OCTN2VT, a splice variant of OCTN2, does not transport carnitine because of the retention in the endoplasmic reticulum caused by insertion of 24 amino acids in the first extracellular loop of OCTN2.</title>
<authorList>
<person name="Maekawa S."/>
<person name="Mori D."/>
<person name="Nishiya T."/>
<person name="Takikawa O."/>
<person name="Horinouchi T."/>
<person name="Nishimoto A."/>
<person name="Kajita E."/>
<person name="Miwa S."/>
</authorList>
<dbReference type="PubMed" id="17509700"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2007.04.005"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="J. Pharmacol. Exp. Ther." volume="290" first="1482" last="1492">
<title>Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.</title>
<authorList>
<person name="Wu X."/>
<person name="Huang W."/>
<person name="Prasad P.D."/>
<person name="Seth P."/>
<person name="Rajan D.P."/>
<person name="Leibach F.H."/>
<person name="Chen J."/>
<person name="Conway S.J."/>
<person name="Ganapathy V."/>
</authorList>
<dbReference type="PubMed" id="10454528"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57 AND ASN-91</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-486</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-550</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="261" first="484" last="487">
<title>Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality.</title>
<authorList>
<person name="Burwinkel B."/>
<person name="Kreuder J."/>
<person name="Schweitzer S."/>
<person name="Vorgerd M."/>
<person name="Gempel K."/>
<person name="Gerbitz K.-D."/>
<person name="Kilimann M.W."/>
</authorList>
<dbReference type="PubMed" id="10425211"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.1060"/>
</citation>
<scope>VARIANT CDSP GLN-169</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Hum. Genet." volume="105" first="157" last="161">
<title>Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency.</title>
<authorList>
<person name="Vaz F.M."/>
<person name="Scholte H.R."/>
<person name="Ruiter J."/>
<person name="Hussaarts-Odijk L.M."/>
<person name="Rodrigues Pereira R."/>
<person name="Schweitzer S."/>
<person name="de Klerk J.B.C."/>
<person name="Waterham H.R."/>
<person name="Wanders R.J.A."/>
</authorList>
<dbReference type="PubMed" id="10480371"/>
<dbReference type="DOI" id="10.1007/s004399900105"/>
</citation>
<scope>VARIANT CDSP CYS-211</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="655" last="660">
<title>Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency.</title>
<authorList>
<person name="Tang N.L."/>
<person name="Ganapathy V."/>
<person name="Wu X."/>
<person name="Hui J."/>
<person name="Seth P."/>
<person name="Yuen P.M."/>
<person name="Wanders R.J."/>
<person name="Fok T.F."/>
<person name="Hjelm N.M."/>
</authorList>
<dbReference type="PubMed" id="10072434"/>
<dbReference type="DOI" id="10.1093/hmg/8.4.655"/>
</citation>
<scope>VARIANT CDSP LEU-478</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="2247" last="2254">
<title>Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency.</title>
<authorList>
<person name="Koizumi A."/>
<person name="Nozaki J."/>
<person name="Ohura T."/>
<person name="Kayo T."/>
<person name="Wada Y."/>
<person name="Nezu J."/>
<person name="Ohashi R."/>
<person name="Tamai I."/>
<person name="Shoji Y."/>
<person name="Takada G."/>
<person name="Kibira S."/>
<person name="Matsuishi T."/>
<person name="Tsuji A."/>
</authorList>
<dbReference type="PubMed" id="10545605"/>
<dbReference type="DOI" id="10.1093/hmg/8.12.2247"/>
</citation>
<scope>VARIANTS CDSP LEU-179; CYS-283 AND CYS-467</scope>
<scope>CHARACTERIZATION OF VARIANTS CDSP LEU-179; CYS-283 AND CYS-467</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="33388" last="33392">
<title>Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.</title>
<authorList>
<person name="Seth P."/>
<person name="Wu X."/>
<person name="Huang W."/>
<person name="Leibach F.H."/>
<person name="Ganapathy V."/>
</authorList>
<dbReference type="PubMed" id="10559218"/>
<dbReference type="DOI" id="10.1074/jbc.274.47.33388"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT CDSP LEU-478</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="118" last="118">
<title>Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency.</title>
<authorList>
<person name="Mayatepek E."/>
<person name="Nezu J."/>
<person name="Tamai I."/>
<person name="Oku A."/>
<person name="Katsura M."/>
<person name="Shimane M."/>
<person name="Tsuji A."/>
</authorList>
<dbReference type="PubMed" id="10612840"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200001)15:1&lt;118::AID-HUMU28>3.0.CO;2-8"/>
</citation>
<scope>VARIANTS CDSP ARG-283 AND PHE-446</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="238" last="245">
<title>A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.</title>
<authorList>
<person name="Wang Y."/>
<person name="Kelly M.A."/>
<person name="Cowan T.M."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="10679939"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200003)15:3&lt;238::AID-HUMU4>3.0.CO;2-3"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT CDSP LYS-452</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="16" first="401" last="407">
<title>Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.</title>
<authorList>
<person name="Wang Y."/>
<person name="Taroni F."/>
<person name="Garavaglia B."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="11058897"/>
<dbReference type="DOI" id="10.1002/1098-1004(200011)16:5&lt;401::AID-HUMU4>3.0.CO;2-J"/>
</citation>
<scope>VARIANTS CDSP TRP-169; VAL-242; ASP-301 AND ARG-351</scope>
<scope>CHARACTERIZATION OF VARIANTS CDSP TRP-169; VAL-242; ASP-301 AND ARG-351</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Genet. Med." volume="3" first="387" last="392">
<title>Phenotype and genotype variation in primary carnitine deficiency.</title>
<authorList>
<person name="Wang Y."/>
<person name="Korman S.H."/>
<person name="Ye J."/>
<person name="Gargus J.J."/>
<person name="Gutman A."/>
<person name="Taroni F."/>
<person name="Garavaglia B."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="11715001"/>
<dbReference type="DOI" id="10.1097/00125817-200111000-00002"/>
</citation>
<scope>VARIANTS CDSP PRO-19 AND GLN-399</scope>
<scope>CHARACTERIZATION OF VARIANTS CDSP PRO-19 AND GLN-399</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="J. Inherit. Metab. Dis." volume="27" first="778" last="780">
<title>Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy.</title>
<authorList>
<person name="Makhseed N."/>
<person name="Vallance H.D."/>
<person name="Potter M."/>
<person name="Waters P.J."/>
<person name="Wong L.T.K."/>
<person name="Lillquist Y."/>
<person name="Pasquali M."/>
<person name="Amat di San Filippo C."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="15617188"/>
<dbReference type="DOI" id="10.1023/B:BOLI.0000045837.23328.f4"/>
</citation>
<scope>VARIANT CDSP LEU-83</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="25" first="306" last="313">
<title>Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene.</title>
<authorList>
<person name="Dobrowolski S.F."/>
<person name="McKinney J.T."/>
<person name="Amat di San Filippo C."/>
<person name="Giak Sim K."/>
<person name="Wilcken B."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="15714519"/>
<dbReference type="DOI" id="10.1002/humu.20137"/>
</citation>
<scope>VARIANTS CDSP PRO-19; LEU-83; TRP-169; MET-232; VAL-242; ASP-301; ARG-351; GLN-399; CYS-447; ASP-449; LYS-452 AND ARG-468</scope>
<scope>CHARACTERIZATION OF VARIANTS MET-232 AND ARG-468</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Mol. Pharmacol." volume="70" first="1602" last="1611">
<title>Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).</title>
<authorList>
<person name="Urban T.J."/>
<person name="Gallagher R.C."/>
<person name="Brown C."/>
<person name="Castro R.A."/>
<person name="Lagpacan L.L."/>
<person name="Brett C.M."/>
<person name="Taylor T.R."/>
<person name="Carlson E.J."/>
<person name="Ferrin T.E."/>
<person name="Burchard E.G."/>
<person name="Packman S."/>
<person name="Giacomini K.M."/>
</authorList>
<dbReference type="PubMed" id="16931768"/>
<dbReference type="DOI" id="10.1124/mol.106.028126"/>
</citation>
<scope>VARIANTS PHE-144; ILE-481; PHE-481; LEU-508; VAL-530 AND SER-549</scope>
<scope>VARIANTS CDSP LEU-17 AND ASP-449</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="Mol. Genet. Metab." volume="90" first="441" last="445">
<title>Expanded newborn screening identifies maternal primary carnitine deficiency.</title>
<authorList>
<person name="Schimmenti L.A."/>
<person name="Crombez E.A."/>
<person name="Schwahn B.C."/>
<person name="Heese B.A."/>
<person name="Wood T.C."/>
<person name="Schroer R.J."/>
<person name="Bentler K."/>
<person name="Cederbaum S."/>
<person name="Sarafoglou K."/>
<person name="McCann M."/>
<person name="Rinaldo P."/>
<person name="Matern D."/>
<person name="di San Filippo C.A."/>
<person name="Pasquali M."/>
<person name="Berry S.A."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="17126586"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2006.10.003"/>
</citation>
<scope>VARIANTS CDSP SER-32; SER-46; CYS-467 AND CYS-488</scope>
<scope>CHARACTERIZATION OF VARIANT CDSP SER-46</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Genet. Med." volume="12" first="19" last="24">
<title>Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects.</title>
<authorList>
<person name="El-Hattab A.W."/>
<person name="Li F.-Y."/>
<person name="Shen J."/>
<person name="Powell B.R."/>
<person name="Bawle E.V."/>
<person name="Adams D.J."/>
<person name="Wahl E."/>
<person name="Kobori J.A."/>
<person name="Graham B."/>
<person name="Scaglia F."/>
<person name="Wong L.-J."/>
</authorList>
<dbReference type="PubMed" id="20027113"/>
<dbReference type="DOI" id="10.1097/GIM.0b013e3181c5e6f7"/>
</citation>
<scope>VARIANTS CDSP TRP-15; SER-46; LEU-83; SER-142; VAL-214; MET-232; TRP-399 AND ILE-442</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1632" last="E1651">
<title>Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency.</title>
<authorList>
<person name="Li F.-Y."/>
<person name="El-Hattab A.W."/>
<person name="Bawle E.V."/>
<person name="Boles R.G."/>
<person name="Schmitt E.S."/>
<person name="Scaglia F."/>
<person name="Wong L.-J."/>
</authorList>
<dbReference type="PubMed" id="20574985"/>
<dbReference type="DOI" id="10.1002/humu.21311"/>
</citation>
<scope>VARIANTS CDSP SER-12; TRP-15; LEU-17; SER-32; SER-46; LEU-83; TYR-122; SER-142; TRP-169; GLN-169; PRO-186; VAL-214; HIS-227; MET-232; TRP-257; ARG-264; GLN-282; LEU-355; LEU-398; TRP-399; MET-440; ILE-442; VAL-443; ASP-449; LYS-452; ARG-455; CYS-467; CYS-488 AND SER-507</scope>
<scope>VARIANTS PRO-66; PRO-75; ALA-96; GLY-123; LEU-143; VAL-177; LEU-230; THR-240; VAL-312; ASN-358 AND SER-549</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Mol. Genet. Metab." volume="100" first="46" last="50">
<title>Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening.</title>
<authorList>
<person name="Lee N.-C."/>
<person name="Tang N.-L."/>
<person name="Chien Y.-H."/>
<person name="Chen C.-A."/>
<person name="Lin S.-J."/>
<person name="Chiu P.-C."/>
<person name="Huang A.-C."/>
<person name="Hwu W.-L."/>
</authorList>
<dbReference type="PubMed" id="20074989"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2009.12.015"/>
</citation>
<scope>VARIANTS CDSP LEU-17; ARG-234; GLN-282; LEU-362; CYS-467 AND CYS-471</scope>
<scope>VARIANT LEU-143</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="118" last="123">
<title>Genotype-phenotype correlation in primary carnitine deficiency.</title>
<authorList>
<person name="Rose E.C."/>
<person name="di San Filippo C.A."/>
<person name="Ndukwe Erlingsson U.C."/>
<person name="Ardon O."/>
<person name="Pasquali M."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="21922592"/>
<dbReference type="DOI" id="10.1002/humu.21607"/>
</citation>
<scope>VARIANTS CDSP TRP-15; PRO-19; PHE-22 DEL; ASN-26; SER-32; SER-46; LEU-83; SER-142; GLN-169; TRP-169; VAL-214; MET-232; PHE-280; GLN-282; ARG-283; ARG-351; MET-440; ILE-442; PHE-446; CYS-447; CYS-467; PRO-471 AND HIS-488</scope>
<scope>CHARACTERIZATION OF VARIANTS CDSP TRP-15; PRO-19; PHE-22 DEL; ASN-26; SER-32; SER-46; LEU-83; GLN-169; TRP-169; VAL-214; MET-232; PHE-280; GLN-282; ARG-283; ARG-351; MET-440; ILE-442; PHE-446; CYS-447; CYS-467 AND PRO-471</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="1684" last="1699">
<title>Functional and molecular studies in primary carnitine deficiency.</title>
<authorList>
<person name="Frigeni M."/>
<person name="Balakrishnan B."/>
<person name="Yin X."/>
<person name="Calderon F.R.O."/>
<person name="Mao R."/>
<person name="Pasquali M."/>
<person name="Longo N."/>
</authorList>
<dbReference type="PubMed" id="28841266"/>
<dbReference type="DOI" id="10.1002/humu.23315"/>
</citation>
<scope>VARIANTS CDSP 4-TYR--PHE-557 DEL; SER-12; TRP-15; LEU-16; LEU-17; PRO-19; HIS-20; PHE-22 DEL; ASN-26; ILE-28; SER-32; VAL-44; LEU-46; SER-46; TYR-50; PRO-66; PRO-75; LEU-83; TRP-93; VAL-95; ALA-96; GLY-115; 117-TRP--PHE-557 DEL; GLY-123; ASP-131; 132-TRP--PHE-557 DEL; 140-TRP--PHE-557 DEL; SER-142; LEU-143; MET-151; GLN-169; PRO-169; TRP-169; MET-175; VAL-177; LEU-179; PRO-186; ARG-205; SER-210; CYS-211; VAL-214; LYS-219; LEU-225; HIS-227; LEU-230; PHE-231; MET-232; THR-240; VAL-242; ARG-247; 254-ARG--PHE-557 DEL; GLN-254; 256-TRP--PHE-557 DEL; TRP-257; ARG-264; MET-264; PRO-269; 275-TRP--PHE-557 DEL; PHE-280; 282-ARG--PHE-557 DEL; GLN-282; ARG-283; CYS-283; 289-ARG--PHE-557 DEL; 295-VAL--PHE-557 DEL; ASP-301; VAL-312; LYS-317; 319-GLN--PHE-557 DEL; THR-348; ARG-351; LEU-355; ASN-358; PRO-363; 387-TYR--PHE-557 DEL; LEU-394 DEL; LEU-398; GLN-399; TRP-399; GLY-412; GLY-439; MET-440; ILE-442; VAL-443; PHE-446; CYS-447; LEU-448; ASP-449; LYS-452; ARG-455; VAL-462; CYS-467; ARG-468; PHE-470; HIS-471; PRO-471; ARG-476; LEU-478; CYS-488; HIS-488 AND SER-507</scope>
<scope>VARIANTS PHE-481 AND SER-549</scope>
<scope>CHARACTERIZATION OF VARIANTS CDSP SER-12; TRP-15; LEU-16; LEU-17; PRO-19; HIS-20; PHE-23 DEL; ASN-26; ILE-28; SER-32; VAL-44; LEU-46; SER-46; TYR-50; PRO-66; PRO-75; LEU-83; TRP-93; VAL-95; ALA-96; GLY-115; GLY-123; ASP-131; SER-142; LEU-143; MET-151; GLN-169; PRO-169; TRP-169; MET-175; VAL-177; LEU-179; PRO-186; ARG-205; SER-210; CYS-211; VAL-214; LYS-219; LEU-225; HIS-227; LEU-230; PHE-231; MET-232; THR-240; VAL-242; ARG-247; GLN-254; TRP-257; ARG-264; MET-264; PRO-269; PHE-280; GLN-282; ARG-283; CYS-283; ASP-301; VAL-312; LYS-317; THR-348; ARG-351; LEU-355; ASN-358; PRO-363; LEU-394 DEL; LEU-398; GLN-399; TRP-399; GLY-412; GLY-439; MET-440; ILE-442; VAL-443; PHE-446; CYS-447; LEU-448; ASP-449; LYS-452; ARG-455; VAL-462; CYS-467; ARG-468; PHE-470; HIS-471; PRO-471; ARG-476; LEU-478; CYS-488; HIS-488 AND SER-507</scope>
<scope>CHARACTERIZATION OF VARIANTS PHE-481 AND SER-549</scope>
</reference>
<comment type="function">
<text evidence="7">Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Also relative uptake activity ratio of carnitine to TEA is 11.3.</text>
</comment>
<comment type="subunit">
<text evidence="3">Interacts with PDZK1.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="12">Membrane</location>
<topology evidence="12">Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O76082-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O76082-2</id>
<name>2</name>
<sequence type="described" ref="VSP_011120 VSP_011121"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>O76082-3</id>
<name>3</name>
<name>OCTN2VT</name>
<sequence type="described" ref="VSP_043904"/>
<text>Retained in the ER, unable to perform carnitine uptake.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7">Strongly expressed in kidney, skeletal muscle, heart and placenta. Highly expressed in intestinal cell types affected by Crohn disease, including epithelial cells. Expressed in CD68 macrophage and CD43 T-cells but not in CD20 B-cells.</text>
</comment>
<comment type="disease" evidence="5 6 8 9 10 11 12 13 14 15 16 17 18 20 21 22 23 24">
<disease id="DI-02356">
<name>Systemic primary carnitine deficiency</name>
<acronym>CDSP</acronym>
<description>Autosomal recessive disorder of fatty acid oxidation caused by defective carnitine transport. Present early in life with hypoketotic hypoglycemia and acute metabolic decompensation, or later in life with skeletal myopathy or cardiomyopathy.</description>
<dbReference type="MIM" id="212140"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Inhibited by emetine, quinidine and verapamil. The IC(50) of emetine is 4.2 uM. Not inhibited by valproic acid.</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family.</text>
</comment>
<comment type="online information" name="The SLC22A5 database">
<link uri="http://www.arup.utah.edu/database/OCTN2/OCTN2_welcome.php"/>
</comment>
<dbReference type="EMBL" id="AF057164">
<property type="protein sequence ID" value="AAC24828.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB015050">
<property type="protein sequence ID" value="BAA29023.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB016625">
<property type="protein sequence ID" value="BAA36712.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB291606">
<property type="protein sequence ID" value="BAF45812.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK128610">
<property type="protein sequence ID" value="BAC87527.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313230">
<property type="protein sequence ID" value="BAG36041.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC118464">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW62337.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW62338.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012325">
<property type="protein sequence ID" value="AAH12325.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4154.1">
<molecule id="O76082-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS78058.1">
<molecule id="O76082-3"/>
</dbReference>
<dbReference type="PIR" id="JW0089">
<property type="entry name" value="JW0089"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295051.1">
<molecule id="O76082-3"/>
<property type="nucleotide sequence ID" value="NM_001308122.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003051.1">
<molecule id="O76082-1"/>
<property type="nucleotide sequence ID" value="NM_003060.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.443572"/>
<dbReference type="ProteinModelPortal" id="O76082"/>
<dbReference type="BioGrid" id="112471">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="IntAct" id="O76082">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000245407"/>
<dbReference type="ChEMBL" id="CHEMBL2073693"/>
<dbReference type="DrugBank" id="DB08842">
<property type="generic name" value="Acetylcarnitine"/>
</dbReference>
<dbReference type="DrugBank" id="DB03128">
<property type="generic name" value="Acetylcholine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04630">
<property type="generic name" value="Aldosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00345">
<property type="generic name" value="Aminohippuric acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00182">
<property type="generic name" value="Amphetamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00415">
<property type="generic name" value="Ampicillin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08795">
<property type="generic name" value="Azidocillin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01053">
<property type="generic name" value="Benzylpenicillin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01140">
<property type="generic name" value="Cefadroxil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00456">
<property type="generic name" value="Cefalotin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00535">
<property type="generic name" value="Cefdinir"/>
</dbReference>
<dbReference type="DrugBank" id="DB01413">
<property type="generic name" value="Cefepime"/>
</dbReference>
<dbReference type="DrugBank" id="DB00671">
<property type="generic name" value="Cefixime"/>
</dbReference>
<dbReference type="DrugBank" id="DB01333">
<property type="generic name" value="Cefradine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00438">
<property type="generic name" value="Ceftazidime"/>
</dbReference>
<dbReference type="DrugBank" id="DB00567">
<property type="generic name" value="Cephalexin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00689">
<property type="generic name" value="Cephaloglycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00122">
<property type="generic name" value="Choline"/>
</dbReference>
<dbReference type="DrugBank" id="DB00501">
<property type="generic name" value="Cimetidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00575">
<property type="generic name" value="Clonidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00148">
<property type="generic name" value="Creatine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01000">
<property type="generic name" value="Cyclacillin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00970">
<property type="generic name" value="Dactinomycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04133">
<property type="generic name" value="Degraded Cephaloridine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01151">
<property type="generic name" value="Desipramine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01075">
<property type="generic name" value="Diphenhydramine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00988">
<property type="generic name" value="Dopamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00668">
<property type="generic name" value="Epinephrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00695">
<property type="generic name" value="Furosemide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00365">
<property type="generic name" value="Grepafloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00536">
<property type="generic name" value="Guanidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05381">
<property type="generic name" value="Histamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00332">
<property type="generic name" value="Ipratropium bromide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00125">
<property type="generic name" value="L-Arginine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00583">
<property type="generic name" value="L-Carnitine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00281">
<property type="generic name" value="Lidocaine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00978">
<property type="generic name" value="Lomefloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB06691">
<property type="generic name" value="Mepyramine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01577">
<property type="generic name" value="Methamphetamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00627">
<property type="generic name" value="Niacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00184">
<property type="generic name" value="Nicotine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00368">
<property type="generic name" value="Norepinephrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01059">
<property type="generic name" value="Norfloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01165">
<property type="generic name" value="Ofloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01032">
<property type="generic name" value="Probenecid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01035">
<property type="generic name" value="Procainamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00908">
<property type="generic name" value="Quinidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00468">
<property type="generic name" value="Quinine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01208">
<property type="generic name" value="Sparfloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08837">
<property type="generic name" value="Tetraethylammonium"/>
</dbReference>
<dbReference type="DrugBank" id="DB00152">
<property type="generic name" value="Thiamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01409">
<property type="generic name" value="Tiotropium"/>
</dbReference>
<dbReference type="DrugBank" id="DB00313">
<property type="generic name" value="Valproic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00661">
<property type="generic name" value="Verapamil"/>
</dbReference>
<dbReference type="TCDB" id="2.A.1.19.3">
<property type="family name" value="the major facilitator superfamily (mfs)"/>
</dbReference>
<dbReference type="iPTMnet" id="O76082"/>
<dbReference type="PhosphoSitePlus" id="O76082"/>
<dbReference type="BioMuta" id="SLC22A5"/>
<dbReference type="MaxQB" id="O76082"/>
<dbReference type="PaxDb" id="O76082"/>
<dbReference type="PeptideAtlas" id="O76082"/>
<dbReference type="PRIDE" id="O76082"/>
<dbReference type="DNASU" id="6584"/>
<dbReference type="Ensembl" id="ENST00000245407">
<molecule id="O76082-1"/>
<property type="protein sequence ID" value="ENSP00000245407"/>
<property type="gene ID" value="ENSG00000197375"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000435065">
<molecule id="O76082-3"/>
<property type="protein sequence ID" value="ENSP00000402760"/>
<property type="gene ID" value="ENSG00000197375"/>
</dbReference>
<dbReference type="GeneID" id="6584"/>
<dbReference type="KEGG" id="hsa:6584"/>
<dbReference type="UCSC" id="uc003kww.5">
<molecule id="O76082-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6584"/>
<dbReference type="DisGeNET" id="6584"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000197375.12"/>
<dbReference type="GeneCards" id="SLC22A5"/>
<dbReference type="GeneReviews" id="SLC22A5"/>
<dbReference type="HGNC" id="HGNC:10969">
<property type="gene designation" value="SLC22A5"/>
</dbReference>
<dbReference type="HPA" id="HPA063062"/>
<dbReference type="MalaCards" id="SLC22A5"/>
<dbReference type="MIM" id="212140">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603377">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O76082"/>
<dbReference type="OpenTargets" id="ENSG00000197375"/>
<dbReference type="Orphanet" id="158">
<property type="disease" value="Systemic primary carnitine deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA333"/>
<dbReference type="eggNOG" id="ENOG410IRIE">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XSRI">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118852"/>
<dbReference type="HOGENOM" id="HOG000234570"/>
<dbReference type="HOVERGEN" id="HBG061545"/>
<dbReference type="InParanoid" id="O76082"/>
<dbReference type="KO" id="K08202"/>
<dbReference type="OMA" id="NIRMVTI"/>
<dbReference type="OrthoDB" id="EOG091G05AC"/>
<dbReference type="PhylomeDB" id="O76082"/>
<dbReference type="TreeFam" id="TF315847"/>
<dbReference type="Reactome" id="R-HSA-200425">
<property type="pathway name" value="Import of palmitoyl-CoA into the mitochondrial matrix"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-549127">
<property type="pathway name" value="Organic cation transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5619053">
<property type="pathway name" value="Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP)"/>
</dbReference>
<dbReference type="GeneWiki" id="SLC22A5"/>
<dbReference type="GenomeRNAi" id="6584"/>
<dbReference type="PRO" id="PR:O76082"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000197375"/>
<dbReference type="CleanEx" id="HS_SLC22A5"/>
<dbReference type="ExpressionAtlas" id="O76082">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O76082">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031526">
<property type="term" value="C:brush border membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0015226">
<property type="term" value="F:carnitine transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015491">
<property type="term" value="F:cation:cation antiporter activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015238">
<property type="term" value="F:drug transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008514">
<property type="term" value="F:organic anion transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030165">
<property type="term" value="F:PDZ domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015651">
<property type="term" value="F:quaternary ammonium group transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015293">
<property type="term" value="F:symporter activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0009437">
<property type="term" value="P:carnitine metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1902603">
<property type="term" value="P:carnitine transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0015879">
<property type="term" value="P:carnitine transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015893">
<property type="term" value="P:drug transport"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060731">
<property type="term" value="P:positive regulation of intestinal epithelial structure maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015697">
<property type="term" value="P:quaternary ammonium group transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052106">
<property type="term" value="P:quorum sensing involved in interaction with host"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006814">
<property type="term" value="P:sodium ion transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070715">
<property type="term" value="P:sodium-dependent organic cation transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd06174">
<property type="entry name" value="MFS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR020846">
<property type="entry name" value="MFS_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR005828">
<property type="entry name" value="MFS_sugar_transport-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036259">
<property type="entry name" value="MFS_trans_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR004749">
<property type="entry name" value="Orgcat_transp/SVOP"/>
</dbReference>
<dbReference type="InterPro" id="IPR005829">
<property type="entry name" value="Sugar_transporter_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00083">
<property type="entry name" value="Sugar_tr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF103473">
<property type="entry name" value="SSF103473"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00898">
<property type="entry name" value="2A0119"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50850">
<property type="entry name" value="MFS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00216">
<property type="entry name" value="SUGAR_TRANSPORT_1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0915">Sodium</keyword>
<keyword id="KW-0739">Sodium transport</keyword>
<keyword id="KW-0769">Symport</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="chain" description="Solute carrier family 22 member 5" id="PRO_0000220500">
<location>
<begin position="1"/>
<end position="557"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="4">
<location>
<begin position="21"/>
<end position="41"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="42"/>
<end position="142"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="4">
<location>
<begin position="143"/>
<end position="163"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="164"/>
<end position="172"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="4">
<location>
<begin position="173"/>
<end position="193"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="194"/>
<end position="197"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="4">
<location>
<begin position="198"/>
<end position="218"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="219"/>
<end position="232"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="4">
<location>
<begin position="233"/>
<end position="253"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="254"/>
<end position="257"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="4">
<location>
<begin position="258"/>
<end position="278"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="279"/>
<end position="341"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="4">
<location>
<begin position="342"/>
<end position="362"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="363"/>
<end position="373"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=8" evidence="4">
<location>
<begin position="374"/>
<end position="394"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="395"/>
<end position="406"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=9" evidence="4">
<location>
<begin position="407"/>
<end position="427"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="428"/>
<end position="430"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=10" evidence="4">
<location>
<begin position="431"/>
<end position="451"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="452"/>
<end position="462"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=11" evidence="4">
<location>
<begin position="463"/>
<end position="483"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="484"/>
<end position="488"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=12" evidence="4">
<location>
<begin position="489"/>
<end position="509"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="4">
<location>
<begin position="218"/>
<end position="225"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="1">
<location>
<position position="486"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2">
<location>
<position position="550"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="57"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="64"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="91"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_011120" evidence="25">
<location>
<begin position="1"/>
<end position="336"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_043904" evidence="26">
<original>E</original>
<variation>EQDSGAYNAMKNRMGKKPALCLPAQ</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_011121" evidence="25">
<original>TWNIRMVTIMSIMLW</original>
<variation>MWILLFQLSSALCFR</variation>
<location>
<begin position="337"/>
<end position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079640" evidence="24">
<location>
<begin position="4"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains 50% of wild-type activity; dbSNP:rs139203363." id="VAR_064109" evidence="22 24">
<original>G</original>
<variation>S</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 20% of wild-type; dbSNP:rs267607052." id="VAR_064110" evidence="20 22 23 24">
<original>G</original>
<variation>W</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_079641" evidence="24">
<original>P</original>
<variation>L</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 20% of wild-type; dbSNP:rs11568520." id="VAR_020347" evidence="17 21 22 24">
<original>F</original>
<variation>L</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport is reduced to less than 5% of normal; dbSNP:rs72552723." id="VAR_064111" evidence="14 16 23 24">
<original>R</original>
<variation>P</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains 50% of wild-type activity; dbSNP:rs144020613." id="VAR_079642" evidence="24">
<original>L</original>
<variation>H</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of normal." id="VAR_066842" evidence="23 24">
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 6% of wild-type; dbSNP:rs772578415." id="VAR_066843" evidence="23 24">
<original>S</original>
<variation>N</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to 1% of wild-type; dbSNP:rs72552724." id="VAR_079643" evidence="24">
<original>S</original>
<variation>I</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 1% of wild-type; dbSNP:rs72552725." id="VAR_064112" evidence="18 22 23 24">
<original>N</original>
<variation>S</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 10% of wild-type; dbSNP:rs199689597." id="VAR_079644" evidence="24">
<original>A</original>
<variation>V</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 5% of wild-type; dbSNP:rs377767445." id="VAR_079645" evidence="24">
<original>P</original>
<variation>L</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport is reduced to less than 5% of normal; dbSNP:rs202088921." id="VAR_064113" evidence="18 20 22 23 24">
<original>P</original>
<variation>S</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_079646" evidence="24">
<original>C</original>
<variation>Y</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to 2% of wild-type." id="VAR_064114" evidence="22 24">
<original>T</original>
<variation>P</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to 2% of wild-type; dbSNP:rs757711838." id="VAR_064115" evidence="22 24">
<original>R</original>
<variation>P</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs72552726." id="VAR_064116" evidence="15 16 20 22 23 24">
<original>R</original>
<variation>L</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134190." id="VAR_079647" evidence="24">
<original>S</original>
<variation>W</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains 30% of wild-type activity; dbSNP:rs386134191." id="VAR_079648" evidence="24">
<original>L</original>
<variation>V</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to 20% of wild-type; dbSNP:rs377767450." id="VAR_064117" evidence="22 24">
<original>G</original>
<variation>A</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 5% of wild-type; dbSNP:rs386134192." id="VAR_079649" evidence="24">
<original>D</original>
<variation>G</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079650" evidence="24">
<location>
<begin position="117"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; dbSNP:rs201082652." id="VAR_064118" evidence="22">
<original>D</original>
<variation>Y</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 20% of wild-type; dbSNP:rs748605096." id="VAR_064119" evidence="22 24">
<original>V</original>
<variation>G</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; may affect splicing; unknown pathological significance; reduces carnitine transport but the mutant retains 30% of wild-type activity." id="VAR_079651" evidence="24">
<original>E</original>
<variation>D</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079652" evidence="24">
<location>
<begin position="132"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079653" evidence="24">
<location>
<begin position="140"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains more than 25% of wild-type activity; dbSNP:rs151231558." id="VAR_064120" evidence="20 22 23 24">
<original>A</original>
<variation>S</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 2% of wild-type." id="VAR_064121" evidence="21 22 24">
<original>P</original>
<variation>L</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10040427." id="VAR_020348" evidence="17">
<original>L</original>
<variation>F</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains more than 60% of wild-type activiy; dbSNP:rs386134193." id="VAR_079654" evidence="24">
<original>V</original>
<variation>M</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_079655" evidence="24">
<original>R</original>
<variation>P</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs121908889." id="VAR_009252" evidence="6 22 23 24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs121908890." id="VAR_064122" evidence="13 16 22 23 24">
<original>R</original>
<variation>W</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 10% of wild-type; dbSNP:rs781721860." id="VAR_079656" evidence="24">
<original>V</original>
<variation>M</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport reduced to less than 20% of wild-type; dbSNP:rs145068530." id="VAR_064123" evidence="22 24">
<original>M</original>
<variation>V</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains more than 40% of wild-type activiy; dbSNP:rs386134196." id="VAR_022564" evidence="9 24">
<original>M</original>
<variation>L</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134197." id="VAR_064124" evidence="22 24">
<original>L</original>
<variation>P</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_079657" evidence="24">
<original>M</original>
<variation>R</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134198." id="VAR_079658" evidence="24">
<original>N</original>
<variation>S</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs121908888." id="VAR_009253" evidence="8 24">
<original>Y</original>
<variation>C</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains 30% of wild-type activity; dbSNP:rs386134199." id="VAR_064125" evidence="20 22 23 24">
<original>A</original>
<variation>V</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains 30% of wild-type activity." id="VAR_079659" evidence="24">
<original>T</original>
<variation>K</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 20% of wild-type activity; dbSNP:rs386134205." id="VAR_079660" evidence="24">
<original>S</original>
<variation>L</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 10% of wild-type activity; dbSNP:rs185551386." id="VAR_064126" evidence="22 24">
<original>R</original>
<variation>H</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of wild-type activity; dbSNP:rs756650860." id="VAR_064127" evidence="22 24">
<original>F</original>
<variation>L</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134206." id="VAR_079661" evidence="24">
<original>S</original>
<variation>F</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 20% of wild-type activity; dbSNP:rs114269482." id="VAR_064128" evidence="16 20 22 23 24">
<original>T</original>
<variation>M</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_064129" evidence="21">
<original>G</original>
<variation>R</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 2% of wild-type activity." id="VAR_064130" evidence="22 24">
<original>A</original>
<variation>T</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs72552728." id="VAR_064131" evidence="13 16 24">
<original>G</original>
<variation>V</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_079662" evidence="24">
<original>P</original>
<variation>R</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079663" evidence="24">
<location>
<begin position="254"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains more than 30% of wild-type activity; dbSNP:rs200699819." id="VAR_079664" evidence="24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079665" evidence="24">
<location>
<begin position="256"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 10% of wild-type activity; dbSNP:rs386134203." id="VAR_064132" evidence="22 24">
<original>R</original>
<variation>W</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains more than 40% of wild-type activity; dbSNP:rs201262157." id="VAR_079666" evidence="24">
<original>T</original>
<variation>M</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 5% of wild-type activity; dbSNP:rs201262157." id="VAR_064133" evidence="22 24">
<original>T</original>
<variation>R</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains more than 40% of wild-type activity." id="VAR_079667" evidence="24">
<original>L</original>
<variation>P</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079668" evidence="24">
<location>
<begin position="275"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of wild-type activity; dbSNP:rs386134208." id="VAR_066844" evidence="23 24">
<original>S</original>
<variation>F</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079669" evidence="24">
<location>
<begin position="282"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to 5% of wild-type activity; dbSNP:rs386134210." id="VAR_064134" evidence="21 22 23 24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134211." id="VAR_022565" evidence="9 24">
<original>W</original>
<variation>C</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of wild-type activity; dbSNP:rs72552729." id="VAR_009254" evidence="11 23 24">
<original>W</original>
<variation>R</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079670" evidence="24">
<location>
<begin position="289"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079671" evidence="24">
<location>
<begin position="295"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less-than-1% to 3% of wild-type activity; dbSNP:rs72552730." id="VAR_064135" evidence="13 16 24">
<original>A</original>
<variation>D</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains 70% of wild-type activity; dbSNP:rs77300588." id="VAR_064136" evidence="22 24">
<original>I</original>
<variation>V</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; no effect on carnitine transport; dbSNP:rs774792831." id="VAR_079672" evidence="24">
<original>E</original>
<variation>K</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079673" evidence="24">
<location>
<begin position="319"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport but the mutant retains 60% of wild-type activity; dbSNP:rs150544263." id="VAR_079674" evidence="24">
<original>I</original>
<variation>T</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs68018207." id="VAR_064137" evidence="13 16 23 24">
<original>W</original>
<variation>R</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 2% of wild-type activity." id="VAR_064138" evidence="22 24">
<original>S</original>
<variation>L</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs61731073." id="VAR_064139" evidence="22 24">
<original>Y</original>
<variation>N</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; dbSNP:rs886042092." id="VAR_064140" evidence="21">
<original>S</original>
<variation>L</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134214." id="VAR_079675" evidence="24">
<original>L</original>
<variation>P</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP." id="VAR_079676" evidence="24">
<location>
<begin position="387"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to 5% of wild-type activity." id="VAR_079677" evidence="24">
<location>
<position position="394"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of wild-type activity; dbSNP:rs144547521." id="VAR_064141" evidence="22 24">
<original>P</original>
<variation>L</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; carnitine transport is reduced to less than 1% of normal; dbSNP:rs121908891." id="VAR_064142" evidence="14 16 24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 5% of wild-type activity; dbSNP:rs267607054." id="VAR_064143" evidence="20 22 24">
<original>R</original>
<variation>W</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; no effect on carnitine transport." id="VAR_079678" evidence="24">
<original>S</original>
<variation>G</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of wild-type activity." id="VAR_079679" evidence="24">
<original>V</original>
<variation>G</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs72552732." id="VAR_064144" evidence="22 23 24">
<original>T</original>
<variation>M</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; requires 2 nucleotide substitutions; reduces carnitine transport to less than 20% of wild-type activity; dbSNP:rs267607053." id="VAR_064145" evidence="20 22 23 24">
<original>A</original>
<variation>I</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of wild-type." id="VAR_064146" evidence="22 24">
<original>F</original>
<variation>V</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 1% of wild-type; dbSNP:rs72552733." id="VAR_009255" evidence="11 23 24">
<original>V</original>
<variation>F</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134218." id="VAR_064147" evidence="16 23 24">
<original>Y</original>
<variation>C</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 20% of wild-type; dbSNP:rs386134219." id="VAR_079680" evidence="24">
<original>V</original>
<variation>L</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport to less than 20% of wild-type; dbSNP:rs11568514." id="VAR_029315" evidence="16 17 22 24">
<original>Y</original>
<variation>D</variation>
<location>
<position position="449"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 5% of wild-type; dbSNP:rs72552734." id="VAR_009256" evidence="12 16 22 24">
<original>E</original>
<variation>K</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_064148" evidence="22 24">
<original>P</original>
<variation>R</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 5% of wild-type." id="VAR_079681" evidence="24">
<original>G</original>
<variation>V</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 20% of wild-type activity; dbSNP:rs60376624." id="VAR_022566" evidence="9 18 21 22 23 24">
<original>S</original>
<variation>C</variation>
<location>
<position position="467"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; markedly reduced carnitine transport compared to the wild-type protein; less than 1% of wild-type activity; dbSNP:rs386134221." id="VAR_064149" evidence="16 24">
<original>T</original>
<variation>R</variation>
<location>
<position position="468"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport; dbSNP:rs386134222." id="VAR_079682" evidence="24">
<original>S</original>
<variation>F</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; dbSNP:rs749282641." id="VAR_064150" evidence="21">
<original>R</original>
<variation>C</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 2% of wild-type; dbSNP:rs386134223." id="VAR_079683" evidence="24">
<original>R</original>
<variation>H</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_066845" evidence="23 24">
<original>R</original>
<variation>P</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport." id="VAR_079684" evidence="24">
<original>L</original>
<variation>R</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; loss of carnitine transport but stimulated organic cation transport; dbSNP:rs72552735." id="VAR_009257" evidence="5 10 24">
<original>P</original>
<variation>L</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; reduces carnitine transport but the mutant retains more than 60% of wild-type activity; dbSNP:rs11568513." id="VAR_020349" evidence="17 24">
<original>V</original>
<variation>F</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11568513." id="VAR_036816" evidence="17">
<original>V</original>
<variation>I</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to less than 10% of wild-type; dbSNP:rs377216516." id="VAR_064151" evidence="18 22 24">
<original>R</original>
<variation>C</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; unknown pathological significance; reduces carnitine transport to 40% of wild-type; dbSNP:rs28383481." id="VAR_066846" evidence="23 24">
<original>R</original>
<variation>H</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In CDSP; reduces carnitine transport to 5% of wild-type." id="VAR_064152" evidence="22 24">
<original>L</original>
<variation>S</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11568521." id="VAR_029316" evidence="17">
<original>F</original>
<variation>L</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11568524." id="VAR_029317" evidence="17">
<original>M</original>
<variation>V</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; reduces carnitine transport but the mutant retains more than 20% of wild-type activity; dbSNP:rs11568525." id="VAR_020350" evidence="17 22 24">
<original>P</original>
<variation>S</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of both carnitine and organic cation transport functionalities." evidence="10">
<original>M</original>
<variation>R</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAH12325." ref="8" evidence="27">
<original>L</original>
<variation>P</variation>
<location>
<position position="114"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10072434"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10425211"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10454528"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10480371"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10545605"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10559218"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10612840"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10679939"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11058897"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11715001"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15617188"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15714519"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16931768"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17126586"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20027113"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20074989"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20574985"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21922592"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28841266"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17509700"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="557" mass="62752" checksum="928B1F6EFF63C48D" modified="1998-11-01" version="1">
MRDYDEVTAFLGEWGPFQRLIFFLLSASIIPNGFTGLSSVFLIATPEHRCRVPDAANLSS
AWRNHTVPLRLRDGREVPHSCRRYRLATIANFSALGLEPGRDVDLGQLEQESCLDGWEFS
QDVYLSTIVTEWNLVCEDDWKAPLTISLFFVGVLLGSFISGQLSDRFGRKNVLFVTMGMQ
TGFSFLQIFSKNFEMFVVLFVLVGMGQISNYVAAFVLGTEILGKSVRIIFSTLGVCIFYA
FGYMVLPLFAYFIRDWRMLLVALTMPGVLCVALWWFIPESPRWLISQGRFEEAEVIIRKA
AKANGIVVPSTIFDPSELQDLSSKKQQSHNILDLLRTWNIRMVTIMSIMLWMTISVGYFG
LSLDTPNLHGDIFVNCFLSAMVEVPAYVLAWLLLQYLPRRYSMATALFLGGSVLLFMQLV
PPDLYYLATVLVMVGKFGVTAAFSMVYVYTAELYPTVVRNMGVGVSSTASRLGSILSPYF
VYLGAYDRFLPYILMGSLTILTAILTLFLPESFGTPLPDTIDQMLRVKGMKHRKTPSHTR
MLKDGQERPTILKSTAF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>